Soligenix Inc
(NASDAQ:SNGX)
$0.4518
0.0006[0.13%]
Last update: 12:46PM (Delayed 15-Minutes)
Get Real Time Here
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soligenix Stock (NASDAQ:SNGX), Quotes and News Summary

Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.437 - 0.48052 Wk Range0.380 - 1.000Open / Close0.480 / -Float / Outstanding43.176M / 43.335M
Vol / Avg.185.549K / 90.321KMkt Cap19.579MP/E-50d Avg. Price0.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float43.176MEPS-0.340
InvestorPlace - Dec 16, 2022, 12:09PM
Sector: Health Care.Industry: Biotechnology
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-28
REV
Q3 2022Est.ActualSurprise
EPS-0.090-0.080 0.0100
REV200.000K200.000K0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Soligenix (SNGX) stock?

A

You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Soligenix's (SNGX) competitors?

Q

What is the target price for Soligenix (SNGX) stock?

A

The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Soligenix (SNGX)?

A

The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.

Q

Does Soligenix (SNGX) pay a dividend?

A

There are no upcoming dividends for Soligenix.

Q

When is Soligenix (NASDAQ:SNGX) reporting earnings?

A

Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.

Q

Is Soligenix (SNGX) going to split?

A

There is no upcoming split for Soligenix.

Q

What sector and industry does Soligenix (SNGX) operate in?

A

Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.